|
Anorexia and Involuntary Hospitalization:
What if the “cure” is worse than the “illness”?
Chris
Kraatz, Ph.D.
Senior Lecturer in Philosophy
Indiana University - Purdue University Indianapolis
Abstract
A significant minority (approximately 15%) of patients
hospitalized for anorexia nervosa
are hospitalized involuntarily. Discussions about whether or not
this practice is
ethical have been focused almost entirely on the general issues of
paternalism and
protection from self harm. While these issues are certainly
relevant, I aim to take the
discussion in a different direction that is more specific to eating
disorders.
Presumably, a defense of involuntary hospitalizations as
legitimate and ethical would
have to include some reference to empirical data which indicate a
tangible benefit for
anorexic patients. No such data, however, exist. Recent published
research, however,
strongly suggests that
involuntary hospitalization itself presents significant risks for
anorexic patients that should not be ignored, the most disturbing of
which is that involuntary patients have at least four times the mortality rate of their voluntary peers. Based on
these demonstrated
risks, I argue that a moratorium on such involuntary
hospitalizations is necessary.
In light of these facts, the defining question inevitably
becomes one of why a practice
with such demonstrated risks and undemonstrated benefits, a track
record which would not
be permitted to continue in any other area of healthcare, would be
so common and
unquestioned in the field of eating disorders? In response to this
defining question, I
propose consideration of two relevant and troubling observations:
- that the overwhelming
majority of people in positions to decide whether or not
anorexic
patients will be involuntarily hospitalized (doctors and judges)
are men while the
overwhelming majority of people rendered powerless and put at
risk by these decisions
(anorexics) are women, and
- that the financial
rewards for institutions providing in-patient treatment for
anorexia
are lucrative, averaging in excess of $47,000 per patient.
|